Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRPA1 Antagonist A-967079 for BAM8-22 Induced Itch
NCT05249387Completed
- Sponsor
- Aalborg University
- Start
- Feb 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of A-967079 in pruritus (2 arms), sponsored by Aalborg University. Primary endpoints: superficial blood perfusion at 10 minutes, Warm Detection Threshold at 10 minutes and 7 more. Started Feb 2022; status: completed.
02
Drugs
A-967079
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT05249387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05249387.